Financhill
Sell
36

MED Quote, Financials, Valuation and Earnings

Last price:
$13.00
Seasonality move :
18.65%
Day range:
$12.61 - $13.03
52-week range:
$11.57 - $27.16
Dividend yield:
0%
P/E ratio:
69.44x
P/S ratio:
0.26x
P/B ratio:
0.68x
Volume:
177.3K
Avg. volume:
227.7K
1-year change:
-48.33%
Market cap:
$143M
Revenue:
$602.5M
EPS (TTM):
-$0.65

Earnings Data

Next earnings date for MED
Aug 05
2025
Most recent earnings per share
-$0.07
Beat by $0.18
(Apr 28/2025)
Consensus Estimate
-$0.25
(Apr 28/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MED Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/05/2025 Q2 $96.1M -- -- -$0.22 --
04/28/2025 Q1 $116.4M $115.7M -$0.07 -$0.25 $0.18
02/18/2025 Q4 $114.3M $119M $0.07 -$0.16 $0.23
11/04/2024 Q3 $138.2M $140.2M $0.10 -$0.19 $0.29
08/05/2024 Q2 $174.1M $168.6M -$0.75 $0.39 -$1.14
04/29/2024 Q1 $173.5M $174.7M $0.76 $0.80 -$0.04
02/20/2024 Q4 $184.2M $191M $0.50 $0.96 -$0.46
11/06/2023 Q3 -- -- $2.12 $1.07 $1.06
08/07/2023 Q2 -- -- $2.77 $1.44 $1.33
05/01/2023 Q1 -- -- $3.67 $2.40 $1.27
02/21/2023 Q4 -- -- $2.43 $2.22 $0.21
11/03/2022 Q3 -- -- $3.27 $1.91 $1.36
08/03/2022 Q2 -- -- $3.42 $3.23 $0.19
05/02/2022 Q1 -- -- $3.59 $3.57 $0.02
02/23/2022 Q4 -- -- $2.91 $2.65 $0.26
11/04/2021 Q3 -- -- $3.56 $2.92 $0.64
08/04/2021 Q2 -- -- $3.96 $3.30 $0.66
05/04/2021 Q1 -- -- $3.46 $2.72 $0.74
02/25/2021 Q4 -- -- $2.36 $2.36 -$0.00
11/02/2020 Q3 -- -- $2.91 $2.49 $0.42
08/05/2020 Q2 -- -- $1.86 $1.84 $0.02
05/05/2020 Q1 -- -- $1.56 $1.32 $0.25
02/26/2020 Q4 -- -- $1.66 $1.08 $0.58
11/07/2019 Q3 -- -- $1.32 $1.33 -$0.00
08/01/2019 Q2 -- -- $1.75 $1.72 $0.03
05/01/2019 Q1 -- -- $1.70 $1.53 $0.17
02/26/2019 Q4 -- -- $1.30 $1.20 $0.11
11/06/2018 Q3 -- -- $1.14 $1.14 --
08/02/2018 Q2 -- -- $1.16 $0.98 $0.18
05/03/2018 Q1 -- -- $1.01 -- --
03/06/2018 Q4 -- -- $0.60 -- --
11/07/2017 Q3 -- -- $0.55 -- --
08/08/2017 Q2 -- -- $0.63 -- --
05/04/2017 Q1 -- -- $0.51 -- --
03/09/2017 Q4 -- -- $0.34 -- --
11/03/2016 Q3 -- -- $0.51 -- --
08/03/2016 Q2 -- -- $0.29 -- --
05/04/2016 Q1 -- -- $0.36 -- --
03/10/2016 Q4 -- -- $0.33 -- --
11/05/2015 Q3 -- -- $0.46 -- --
08/05/2015 Q2 -- -- $0.51 -- --

Medifast Earnings Questions

  • How Much did Medifast Generate in Revenue Last Quarter?

    Medifast reported $115.7M worth of top line sales in its most recent quarter.

  • Did Medifast Beat Earnings Last Quarter?

    Medifast announced earnings per share of -$0.07 which represents a beat of analyst forecast a -$0.25 per share.

  • Is Medifast Profitable?

    Medifast reported $84.2M that represents $7.70 per share over the last quarter.

  • What is the Analyst Consensus for Medifast EPS Next Year?

    Medifast's earnings are forecast to decrease from $0.19 per share to $1.77 per share next year representing a decrease of -80.55%.

  • When is Medifast's Earnings Date?

    Medifast's next earnings date is August 5, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 7

Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.

Buy
77
FARO alert for May 7

Faro Technologies [FARO] is up 34.66% over the past day.

Buy
63
SKX alert for May 7

Skechers USA [SKX] is down 0.07% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock